Business Segments Acorda Therapeutics OTC Markets
Stocks
ACOR
US00484M7002
Biotechnology & Medical Research
|
Market Closed -
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-10.00% | -99.91% |
| 13/24/13 | First Motion for Exclusivity Period Extension Approved For Acorda Therapeutics, Inc. | CI |
| 07/24/07 | Modified First Amended Joint Liquidation Plan Approved for Acorda Therapeutics, Inc. | CI |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Developing Therapies | 19Cr | 15Cr | 13Cr | 12Cr | 12Cr | |||||
Total Assets | 80Cr | 63Cr | 46Cr | 40Cr | 11Cr | |||||
Interest Expense | -2.19Cr | -3.06Cr | -3Cr | -3.02Cr | -3.15Cr | |||||
Income Tax Expense | -12.82L | -80.73L | -51.2L | 3.07Cr | -4.32Cr | |||||
CAPEX | -9.04Cr | -43.9L | -2L | -1L | -3L | |||||
EBT | -27Cr | -11Cr | -11Cr | -3.52Cr | -30Cr | |||||
D&A | 3.4Cr | 4.09Cr | 3.37Cr | 3.27Cr | 3.17Cr | |||||
Operating Income | -31Cr | -7.81Cr | -7.9Cr | -3.53Cr | -26Cr | |||||
Net Income | -27Cr | -9.96Cr | -10Cr | -6.59Cr | -25Cr |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
United States | 19Cr | 15Cr | 13Cr | 12Cr | 12Cr | |||||
Total Assets | 80Cr | 63Cr | 46Cr | 40Cr | 11Cr | |||||
Interest Expense | -2.19Cr | -3.06Cr | -3Cr | -3.02Cr | -3.15Cr | |||||
Income Tax Expense | -12.82L | -80.73L | -51.2L | 3.07Cr | -4.32Cr | |||||
D&A | 3.4Cr | 4.09Cr | 3.37Cr | 3.27Cr | 3.17Cr | |||||
CAPEX | -9.04Cr | -43.9L | -2L | -1L | -3L | |||||
Net Income | -27Cr | -9.96Cr | -10Cr | -6.59Cr | -25Cr | |||||
EBT | -27Cr | -11Cr | -11Cr | -3.52Cr | -30Cr | |||||
Operating Income | -31Cr | -7.81Cr | -7.9Cr | -3.53Cr | -26Cr |
- Stock Market
- Stocks
- ACOR.Q Stock
- ACOR Stock
- Financials Acorda Therapeutics
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
